Exro Technologies Webinar – The New Brain For Electric Motors And Generators
Exro is changing the future of the world’s electric motors and powertrains, with patented technology that gets more from the power that is put into electric motors.
Exro adds a brain to electric motors – using intelligent algorithms and its electronic program module (EPM) that communicates directly with an electric motor and powertrain.
Pelorus Equity Group’s Unique Take On Cannabis Real Estate Lending Webinar
Rob Sechrist, President of Pelorus Equity Group, provides an in depth look at the unique take on Cannabis Real Estate Lending that is empowering operators through their “Value-add” bridge mortgage REIT lending platform. Pelorus was formed in 2010 and since then has funded over $1B in value-add real estate transactions, recently converting to a Mortgage REIT in 2020 to provided an additional 20% in tax savings
Exro adds a brain to electric motors – using intelligent algorithms and its electronic program module (EPM) that communicates directly with an electric motor and powertrain.
VeriJet Personal Private Aviation Webinar
Richard Kane, Founder of VeriJet, explains what personal private aviation is and how incredibly relevant it is today. Richard will talk about the advantages of VeriJet and why it was an excellent concept that is now even stronger than planned. Richard and his team will also go into opportunities for Family Offices to get involved in the company as a partner or passenger.
A National Intelligence Briefing With Lt. Cmdr. Steven Rogers & Engineered Tax Services Webinar
Please join the Family Office Networks Global Community for a National Intelligence Briefing webinar from Steve Rogers. Julio Gonzalez and Michael D’Onofrio will be hosting and bringing perspective from unprecedented new tax directives and real estate advantages.
Orange Grove Bio Pre-Clinical Development Opportunity
Orange Grove Bio (“OGB”) is a preclinical drug development platform focused on driving down the cost of drug discovery and advancing therapies into clinical trials.
They are partnered with leading universities to license transformational medicines. Orange Grove Bio and its university partners streamline the licensing process to speed up the development process to get drugs to market faster and to save time on-patent.
Elevian: Re-Imagine Aging
Groundbreaking research by Elevian’s scientific co-founders (including three Professors from the Harvard Stem Cell Institute) demonstrated that young blood rejuvenates aged animals.
They further discovered that replenishing the protein “GDF11” in aged animals can reproduce the regenerative effects of young blood – research published in Cell and Science and recognized as a top scientific breakthrough!
In animal models, GDF11 has been demonstrated to treat more than a dozen age-related diseases, including heart failure, heart attacks, stroke, Type 2 diabetes, obesity, Alzheimer’s Disease, COPD/emphysema, liver failure, kidney failure and cancer
Elevian has acquired exclusive worldwide patent rights to Harvard’s GDF11 technology. They are developing new medicines that target GDF11, with the potential to treat and prevent many age-related diseases at the same time.
Elevian’s first application uses GDF11 to treat stroke, the #2 cause of death and #1 cause of long-term disability globally. In animal models, GDF11 promotes motor function recovery and survival after stroke.
WHAT YOU WILL LEARN BY ATTENDING THE WEBINAR
Aging is malleable – It is possible to accelerate, slow and even reverse biological aging.
GDF11 plays an important role in aging – Preclinical results suggests that GDF11 has the potential to treat and prevent MANY age-related diseases and promote healthy aging.
Elevian is an exciting investment opportunity – Including a team of leading scientists and drug development veterans, a massive market opportunity, and enormous societal benefit.